HomeCompareVIMGF vs NOBL

VIMGF vs NOBL: Dividend Comparison 2026

VIMGF yields 72.20% · NOBL yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VIMGF wins by $1.14M in total portfolio value
10 years
VIMGF
VIMGF
● Live price
72.20%
Share price
$2.77
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.16M
Annual income
$312,669.66
Full VIMGF calculator →
NOBL
NOBL
● Live price
2.14%
Share price
$106.01
Annual div
$2.27
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$22.8K
Annual income
$246.19
Full NOBL calculator →

Portfolio growth — VIMGF vs NOBL

📍 VIMGF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodVIMGFNOBL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, VIMGF + NOBL cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
VIMGF pays
NOBL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VIMGF
Annual income on $10K today (after 15% tax)
$6,137.18/yr
After 10yr DRIP, annual income (after tax)
$265,769.21/yr
NOBL
Annual income on $10K today (after 15% tax)
$182.19/yr
After 10yr DRIP, annual income (after tax)
$209.26/yr
At 15% tax rate, VIMGF beats the other by $265,559.95/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VIMGF + NOBL for your $10,000?

VIMGF: 50%NOBL: 50%
100% NOBL50/50100% VIMGF
Portfolio after 10yr
$593.7K
Annual income
$156,457.92/yr
Blended yield
26.35%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on VIMGF right now

VIMGF
Analyst Ratings
1
Buy
1
Hold
Consensus: Buy
Price Target
$42.00
+1416.2% upside vs current
Range: $42.00 — $42.00
Altman Z
2.8
Piotroski
6/9
NOBL
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VIMGF buys
0
NOBL buys
0
No recent congressional trades found for VIMGF or NOBL in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricVIMGFNOBL
Forward yield72.20%2.14%
Annual dividend / share$2.00$2.27
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$1.16M$22.8K
Annual income after 10y$312,669.66$246.19
Total dividends collected$996.9K$2.3K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: VIMGF vs NOBL ($10,000, DRIP)

YearVIMGF PortfolioVIMGF Income/yrNOBL PortfolioNOBL Income/yrGap
1← crossover$17,920$7,220.22$10,914$214.34+$7.0KVIMGF
2$31,267$12,092.32$11,897$218.63+$19.4KVIMGF
3$53,174$19,718.24$12,952$222.72+$40.2KVIMGF
4$88,236$31,339.88$14,086$226.62+$74.2KVIMGF
5$143,015$48,602.72$15,302$230.33+$127.7KVIMGF
6$226,649$73,622.99$16,607$233.85+$210.0KVIMGF
7$351,559$109,044.01$18,007$237.18+$333.6KVIMGF
8$534,242$158,074.42$19,508$240.35+$514.7KVIMGF
9$796,140$224,500.96$21,116$243.35+$775.0KVIMGF
10$1,164,540$312,669.66$22,841$246.19+$1.14MVIMGF

VIMGF vs NOBL: Complete Analysis 2026

VIMGFStock

Vimian Group AB (publ) engages in the animal health business worldwide. It operates through Specialty Pharma, MedTech, Diagnostics, and Veterinary Services segments. The company offers proprietary diagnostics, prescription, and non-prescription treatments for preventive care and treatment of chronic conditions for companion animals under the Nextmune brand name; and molecular and immunodiagnostic solutions that are used by laboratories for veterinary specific applications with a focus on livestock and companion animal health markets under the Indical Bioscience brand name. It also provides procurement and tech-driven operations, such as online marketing, and education and HR, as well as a community for veterinary clinics through a membership-based platform under the VetFamily brand name; and orthopedic implants for veterinarians and universities under the Movora brand name. The company was incorporated in 2020 and is headquartered in Stockholm, Sweden.

Full VIMGF Calculator →

NOBLETF

The fund will invest at least 80% of its total assets in component securities of the index. The index contains a minimum of 40 stocks, which are equally weighted, and no single sector is allowed to comprise more than 30% of the index weight. It seeks to remain fully invested at all times in securities and/or financial instruments that, in combination, provide exposure to the returns of the index without regard to market conditions, trends or direction.

Full NOBL Calculator →
📬

Get this VIMGF vs NOBL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VIMGF vs SCHDVIMGF vs JEPIVIMGF vs OVIMGF vs KOVIMGF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.